Firma Tentamus Group, Autor bei Presse-Blog

CONIDIA CONIPHY launched a new service to track fungicide resistance

13. Juni 202513. Juni 2025 Firma Tentamus GroupDienstleistungenagriculture, Crop Protection, Disease Management, dna-sequencing, downy mildew, environment, Fungi RESIST, fungicide resistance, fungicides, Grapevine, nanopore sequencing, resistance monitoring, sample analysis, surveillance system, sustainability

CONIDIA CONIPHY has added a new service to its portfolio to detect and monitor fungicide resistance of downy mildew disease in grapevine. After 5 years of research, development efforts and investment in new DNA/gene sequencing technologies, CONIDIA CONIPHY launched a Mehr

Tentamus North America Spotlights Expert Legionella Testing Services to Address Critical Public Health Risks

9. Juni 202510. Juni 2025 Firma Tentamus GroupBiotechnikbiologicals, contamination, education, facilities, health, legionella, management, outreach, pneumonia, public, safety, services, testing, testing methodologies, water

As the risk of Legionnaires‘ disease remains a critical public health concern, Tentamus North America is reinforcing its commitment to facility safety by highlighting its expert Legionella testing services for industries across the continent. The company is providing advanced, reliable testing solutions Mehr

Accelerating clinical development in Vienna

30. Mai 2025 Firma Tentamus GroupBiotechnikbiotech companies, breakthrough science, clinical development, Clinical Trial Supply, Clinical Trials, effective therapies, expertise, GMP compliance, immunogenicity assays, infrastructure, pharmacodynamic services, pharmacokinetic services, regulatory guidance, trial logistics, vienna

Turning breakthrough science into effective therapies requires more than innovation — it demands the right expertise, infrastructure, and seamless execution. This complexity is addressed by ClinXTrials – a powerhouse alliance based in Vienna. Gouya Insights, VelaLabs – a Tentamus company Mehr

Accelerator für klinischen Entwicklung in Wien

30. Mai 2025 Firma Tentamus GroupBiotechnikbahnbrechende wissenschaftliche Erkenntnisse, Biotechnologieunternehmen, expertise, GMP-Konformität, Immunogenität, infrastruktur, klinische Entwicklung, klinische Studien, klinische Studienlogistik, Pharmakodynamik, Pharmakokinetik, regulatorische Unterstützung, Studienlogistik, wien, wirksame Therapien

Bahnbrechende wissenschaftliche Erkenntnisse in wirksame Therapien zu überführen, erfordert mehr als nur Innovation – es bedarf der richtigen Expertise, Infrastruktur und reibungsloser Durchführung. Diese Komplexität wird bei ClinXTrials adressiert. Gouya Insights, VelaLabs – a Tentamus company – und ABF Pharmaceutical Mehr

The Oldenburg site of Tentamus Pharma & Med Deutschland GmbH celebrates its 30th anniversary this year

27. Mai 2025 Firma Tentamus GroupAllgemein30th anniversary, customer solutions, drug research, GC analytics, herbal medicines, hplc, innovation, laboratory, method transfer, oldenburg, pharmaceutical analytics, quality, stability studies, Tentamus Group

Since its founding in August 1995 as Dr. Kolkmann & Partner GmbH, the company has developed into an established player in the field of pharmaceutical analytics and drug research. Over the course of three decades, the site has undergone an Mehr

30 Jahre pharmazeutische Kompetenz in Oldenburg – Tentamus Pharma & Med Deutschland feiert Jubiläum

27. Mai 2025 Firma Tentamus GroupAllgemein30-jähriges Jubiläum, Arzneimittelforschung, GC-Analytik, hplc, innovation, kundenlösungen, labor, Methodentransfer, oldenburg, pflanzliche Arzneimittel, pharmazeutische Analytik, qualität, Stabilitätsuntersuchungen, Tentamus Group

Der Standort Oldenburg der Tentamus Pharma & Med Deutschland GmbH feiert in diesem Jahr sein 30-jähriges Bestehen. Seit der Gründung im August 1995 als Dr. Kolkmann & Partner GmbH hat sich das Unternehmen zu einer etablierten Größe im Bereich pharmazeutischer Mehr

Record Year for Minerva

22. Mai 202523. Mai 2025 Firma Tentamus GroupForschung und Entwicklungfood safety, heavy metals, honey testing, HPIC system, ICP-MS, ion chromatography, ISO 17025, laboratory services, method development, microwave digestion, minerva scientific, sugar analysis, team leadership, UKAS accreditation

Minerva Scientific – A Tentamus Company is a Food and Feed testing laboratory established in 2001, offering a wide range of ISO 17025 accredited tests ideal for due diligence-based surveillance testing, pertinent to UK and EU legislative requirements. Notably, our Mehr

New in our portfolio: Headspace-SPME GC-MS

21. Mai 202523. Mai 2025 Firma Tentamus GroupBiotechnikanalysis, aromalab, customers, extracts, food, glycol, headspace, new, propylene, samples, spme, technology, testing, toothpaste, with

We now offer a new analytical method, Headspace SPME (solid phase microextraction), which is suitable for routine aroma analysis as well as for special analytical questions! Do you remember our article from last summer, in which we introduced you to Mehr

Wir nehmen Abschied von Karsten Ott – ein geschätzter Geschäftsführer, Kollege und Mensch

13. Mai 202513. Mai 2025 Firma Tentamus GroupFirmeninternanalytik, barsch, berlin, bilacon, Familie, frank, group, kunden, kundinnen, menschen, ott, team, tentamus, unternehmen, wachstum

Karsten Ott war über drei Jahrzehnte eine tragende Säule unseres Unternehmens. Seit seinem Eintritt in die bilacon im Jahr 1992 prägte er maßgeblich die Entwicklung und das Wachstum des Labors. Er leitete bis 2018 mit außerordentlicher Expertise die Abteilung für Mehr

EU to Limit PFAS in Food Packaging by 2026: What You Need to Know

8. Mai 20258. Mai 2025 Firma Tentamus GroupForschung und Entwicklungcircular economy, environmental impact, EU Regulation 2025/40, fluorine content, food packaging, health risks, packaging limits, Pegaso Management, pfas, ppwr, recyclability, Regulatory Compliance, single-use plastic, sustainable packaging, targeted PFAS analysis

New EU Regulation 2025/40 (PPWR) sets strict limits on PFAS in food packaging from August 2026, aiming to reduce environmental and health risks. The European Union has adopted Regulation 2025/40, introducing strict limits on PFAS (per- and polyfluoroalkyl substances) in Mehr

Autor: Firma Tentamus Group